Money

Novo Nordisk inventory surges 7% after Ozempic maker’s newest weight-loss drug exhibits promise

Pulse Reporter
Pulse Reporter
Novo Nordisk inventory surges 7% after Ozempic maker’s newest weight-loss drug exhibits promise




The brand new remedy targets intestine hormone GLP-1 but additionally mimics amylin, a hormone launched by the pancreas that suppresses starvation. Learn Extra

You Might Also Like

Ferrari posts upswing in first-quarter revenue, confirms 2025 steerage

We’re elevating our Nvidia value goal after an incredible quarter and rosy steering

Starbucks’ previously distant CEO has purchased a house in Seattle and he is ordering all workers again to the workplace 4 days per week

Jerome Powell met Jamie Dimon and different CEOs behind closed doorways

U.S. financial system to lose billions as overseas vacationers keep away

Share This Article
Previous Article DeepSeek R1’s daring wager on reinforcement studying: The way it outpaced OpenAI at 3% of the fee DeepSeek R1’s daring wager on reinforcement studying: The way it outpaced OpenAI at 3% of the fee
Next Article IHG Rewards Traveler Credit score Card assessment: Full particulars IHG Rewards Traveler Credit score Card assessment: Full particulars
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More News